Cipmox 500 mg Cipla

£12.00

Cipmox 500 mg amoxicillin research antibiotic from Cipla for in-vitro laboratory studies of bacterial resistance patterns and antimicrobial mechanism analysis. Research use only.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Cipmox 500 mg Cipla
Cipmox 500 mg Cipla
£12.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Understanding Cipmox

Cipmox 500 mg is a beta-lactam antibiotic manufactured by Cipla containing 500 mg amoxicillin trihydrate per capsule for laboratory investigation. This broad-spectrum penicillin derivative enables researchers to examine antimicrobial mechanisms, bacterial resistance patterns, and cell wall synthesis inhibition pathways in controlled experimental conditions. Stroid UK Shop supplies authenticated Cipla products for scientific research applications requiring standardised antibiotic compounds.

Laboratory Applications

Researchers investigate Cipmox 500 mg in bacterial culture studies to analyse minimum inhibitory concentrations, resistance development mechanisms, and beta-lactam ring activity against gram-positive organisms. Studies examine its binding affinity to penicillin-binding proteins and peptidoglycan synthesis disruption in laboratory bacterial strains. The compound enables comparative antimicrobial research alongside other amoxicillin research preparations for comprehensive antibiotic mechanism studies. Investigators also study pharmacokinetic properties and metabolite formation patterns in biochemical assays. Research applications extend to examining synergistic effects with other antimicrobials and evaluating bacterial biofilm disruption capabilities in controlled laboratory environments.

Product Specifications

Cipmox 500 mg Research Specifications
Parameter Value
Active ingredient Amoxicillin trihydrate
Strength 500 mg per capsule
Manufacturer Cipla Ltd
Form Hard gelatine capsules
CAS number 26787-78-0 (trihydrate)
Storage Room temperature, dry conditions

Each laboratory batch undergoes quality verification to ensure consistent research outcomes. Scientists studying antibiotic mechanisms often combine this research with investigations into selective androgen receptor modulators for comprehensive pharmaceutical research programmes examining different therapeutic mechanisms.

Research Compliance Statement

Cipmox 500 mg Cipla is supplied exclusively for in-vitro laboratory research and educational purposes. This product is not intended for human consumption, clinical application, or therapeutic use. Researchers must follow institutional guidelines for antibiotic handling and disposal protocols. Studies involving research peptides and antibiotics require appropriate biosafety measures and waste management procedures in accredited laboratory facilities.

Related